Welcome to Avexxin

Avexxin is a pharmaceutical company focused on developing and commercializing novel small molecule therapeutics for patients with chronic inflammatory conditions. Avexxin's advanced understanding of the biology of the inflammatory process has resulted in a novel therapeutic approach for the treatment of psoriasis and other inflammatory disorders.

Avexxin pipeline status


July 2015

Avexxin Completes Phase I/IIA Study In Psoriasis and Achieves Proof-...